Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $8.9900 (1.35%) ($8.6500 - $9.2400) on Fri. Dec. 28, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.73% (three month average) | RSI | 52 | Latest Price | $8.9900(1.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 2.1% a day on average for past five trading days. | Weekly Trend | IOVA declines -6.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(49%) ARKG(48%) IWO(44%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -2.865% in a week (0% probabilities). VXX(-13%) VIXM(-9%) UUP(-7%) DIA(-5%) TLT(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.865% (StdDev 5.73%) | Hourly BBV | 0 () | Intraday Trend | 1.8% | | | |
|
1 - 5 Day Possible Target | $-7.07(-178.64%) | Resistance Level | $9.2 | 5 Day Moving Average | $8.45(6.39%) | 10 Day Moving Average | $8.67(3.69%) | 20 Day Moving Average | $9.2(-2.28%) | To recent high | -24.6% | To recent low | 19.7% | Market Cap | $1.316b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |